Obesity and the risk of prostate cancer (United States)

被引:26
作者
Bradbury, BD
Wilk, JB
Kaye, JA
机构
[1] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA
[2] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[3] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
关键词
body mass index; matched case-control study; prostatic neoplasms;
D O I
10.1007/s10552-005-0383-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of obesity in prostate cancer etiology remains controversial. A recent report suggested that obese men younger than age 60 may have a lower risk of developing prostate cancer than men the same age who are not obese. The current study used a nested, matched case-control study design and data collected in the General Practice Research Database between January 1991 and December 2001 to assess the association between body mass index (BMI) and the risk of incident prostate cancer. Seven hundred and thirty cases of prostate cancer with adequate information on BMI were identified and matched to 2740 controls on age, sex, general practice, and index date. Obese men (BMI >= 30.0 kilograms [kg]/square of height in meters [m(2)]) were at lower risk of developing prostate cancer (AOR=0.78, 95% CI: 0.56, 1.09) compared to normal weight men (BMI=23.0-24.9 kg/m(2)), and the data best fit an inverse quadratic model for the relation between BMI and the risk of prostate cancer. This study provides modest support for a protective association between obesity and the risk of incident prostate cancer.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 20 条
[1]   Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers [J].
Andersson, SO ;
Wolk, A ;
Bergstrom, R ;
Adami, HO ;
Engholm, G ;
Englund, A ;
Nyren, O .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (05) :385-389
[2]   Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States) [J].
Cerhan, JR ;
Torner, JC ;
Lynch, CF ;
Rubenstein, LM ;
Lemke, JH ;
Cohen, MB ;
Lubaroff, DM ;
Wallace, RB .
CANCER CAUSES & CONTROL, 1997, 8 (02) :229-238
[3]  
FIELD AE, 1994, J CLIN ENDOCR METAB, V79, P1310, DOI 10.1210/jc.79.5.1310
[4]   Prospective study of sex hormone levels and risk of prostate cancer [J].
Gann, PH ;
Hennekens, CH ;
Ma, J ;
Longcope, C ;
Stampfer, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (16) :1118-1126
[5]   Body mass index and risk of prostate cancer in US health professionals [J].
Giovannucci, E ;
Rimm, EB ;
Liu, Y ;
Leitzmann, M ;
Wu, K ;
Stampfer, MJ ;
Willett, WC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (16) :1240-1244
[6]  
GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P343
[7]   Total food consumption and body mass index in relation to prostate cancer risk: A case-control study in Sweden with prospectively collected exposure data [J].
Gronberg, H ;
Damber, L ;
Damber, JE .
JOURNAL OF UROLOGY, 1996, 155 (03) :969-974
[8]  
HENDERSON BE, 1982, CANCER RES, V42, P3232
[9]   Prostate cancer risk and serum levels of insulin and leptin: a population-based study [J].
Hsing, AW ;
Chua, S ;
Gao, YT ;
Gentzschein, E ;
Chang, L ;
Deng, J ;
Stanczyk, FZ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (10) :783-789
[10]  
JICK H, 1995, MAJOR RESOURCE DRUG